Clinical Trials Directory

Trials / Completed

CompletedNCT06439004

The Use of QST to Characterize Somatosensory Functionality

The Use of Quantitative Sensory Testing to Characterize Somatosensory Functionality

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Universitaire Ziekenhuizen KU Leuven · Academic / Other
Sex
All
Age
18 Years – 25 Years
Healthy volunteers
Accepted

Summary

Pain has a significant impact on quality of life and poses an enormous burden on the healthcare system. The subjective nature of pain complicates its mapping and treatment. Quantitative Sensory Testing (QST) aims to characterize the somatosensory phenotype using calibrated stimuli and subjective thresholds. This set of procedures enables quantification of the somatosensory function in small fibers (thinly myelinated Aδ and unmyelinated C), as well as large fibers (thickly myelinated Aβ). In this way, sensory loss (hypoesthesia, hypoalgesia) or sensory gain (hyperesthesia, hyperalgesia, allodynia) can be detected. In this study, the inter-period reproducibility of thirteen QST parameters will be determined on the dominant hand, right forearm, right flank and lower back of 20 healthy volunteers.

Conditions

Interventions

TypeNameDescription
OTHERQuantitative Sensory TestingPerforming QST on the dominant hand, right forearm, right flank and lower back.

Timeline

Start date
2024-09-12
Primary completion
2024-11-20
Completion
2024-11-20
First posted
2024-06-03
Last updated
2024-12-20

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT06439004. Inclusion in this directory is not an endorsement.